Hjem › Neuroendokrine tumorer › Pennsylvania
Neuroendokrine tumorer kliniske forsøg i Pennsylvania
12 studier for Neuroendokrine tumorer søger deltagere på steder i Pennsylvania.
Byer i Pennsylvania
Officiel studietekst (engelsk)
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT06943755Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- The Children's Hospital of Philadelphia (CHOP), Philadelphia
RekruttererFase 1
24 Months – 18 Years · Alle køn · Opdateret 25. sep. 2026 · NCT06441331Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
- Hospital of the University of Pennsylvania, Philadelphia
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT07087054Project: Every Child for Younger Patients With Cancer
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Geisinger Medical Center, Danville
- Penn State Children's Hospital, Hershey
- og 4 flere
RekruttererObservationsstudie
Op til 25 år · Alle køn · Opdateret 25. aug. 2026 · NCT02402244A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
- Crinetics Study Site, Philadelphia
- Crinetics Study Site, Philadelphia
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT07129252Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- Fox Chase Cancer Center, Philadelphia
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. jul. 2026 · NCT05263050CapTemY90 for Grade 2/3 NET Liver Metastases
- University of Pennsylvania, Philadelphia
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 4. jun. 2026 · NCT04339036Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
- University of Pennsylvania, Philadelphia
RekruttererFase 1/2
Alder 20 til 99 · Alle køn · Opdateret 20. apr. 2026 · NCT02174549Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
- Research Facility, Pittsburgh
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. mar. 2026 · NCT05477576A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
- University of Pennsylvania, Philadelphia
RekruttererFase 1/2
Alder 18 til 85 · Alle køn · Opdateret 29. jan. 2026 · NCT06055439Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Penn State Hershey Medical Center, Hershey
- Albert Einstein Healthcare Network, Philadelphia
RekruttererFase 4
Alder 18 til 64 · Alle køn · Opdateret 22. jan. 2026 · NCT04373564SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Philadelphia
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.